Three solvent based methods: spray drying (SD), electrospinning (ES) and air-assisted electrospinning (electroblowing; EB) were used to prepare solid dispersions of itraconazole and Eudragit E. Samples with the same API/polymer ratios were prepared in order to make the three technologies comparable. The structure and morphology of solid dispersions were identified by scanning electron microscopy and solid phase analytical methods such as, X-ray powder diffraction (XRPD), differential scanning calorimetry (DSC) and Raman chemical mapping. Moreover, the residual organic solvents of the solid products were determined by static headspace-gas chromatography/mass spectroscopy measurements and the wettability of samples was characterized by contact angle measurement. The pharmaceutical performance of the three dispersion type, evaluated by dissolution tests, proved to be very similar. According to XRPD and DSC analyses, made after the production, all the solid dispersions were free of any API crystal clusters but about 10 wt% drug crystallinity was observed after three months of storage in the case of the SD samples in contrast to the samples produced by ES and EB in which the polymer matrix preserved the API in amorphous state.
Comparison of spray drying, electroblowing and electrospinning for preparation of Eudragit E and itraconazole solid dispersions

Introduction
Most of the active pharmaceutical ingredients (APIs) are commercialized in tablets or capsules (Anselmo and Mitragotri, 2014) , which are most accepted by patients. Development of cost-efficient technologies for these solid forms of human and animal pharmaceuticals is of great importance.
The solubility of recently discovered APIs is often very poor (Macarron, 2006; Vasconcelos et al., 2007) in the gastrointestinal fluids, resulting in low oral bioavailability (Wong et al., 2006) . Methods that are available to eliminate the solubility problem (Fahr and Liu, 2007; Sarode et al., 2014) are either costly or their industrial applicability is limited .
The dissolution rate of APIs belonging to, the BCS II group can effectively be improved by use of salt forms with enhanced dissolution profiles (Agharkar et al., 1976) , by solubilisation of drugs in co-solvents (Amin et al., 2004) , by micellar solutions (Torchilin, 2007) , by formation of water-soluble complexes (Casella et al., 1998) , by use of lipidic systems for the delivery of lipophilic drugs (Humberstone and Charman, 1997) , by increasing the specific surface area of the API according to the Noyes-Whitney equation (Kawabata et al., 2011; Whitney and Noyes, 1897) or by forming solid dispersions of amorphous APIs (Sekiguchi et al., 1964; Simonelli et al., 1969; van Drooge et al., 2006) . The combinations of the last two mentioned methods can be achieved by solvent based technologies, such as spray drying (SD) and electrospinning (ES).
Although SD is widely used in pharmaceutical technology for preparing micro-and/or nanoparticles (Asker and Becker, 1966; Draheim et al., 2015; Fontana et al., 2014) , it has some disadvantages. SD technologies are energy consuming, heat-sensitive APIs can be decomposed during the drying process, and furthermore, the separation and handling of the produced fine powder can cause difficulties (Broadhead et al., 1992; Cal and Sollohub, 2010) .
ES is a facile and straightforward process for creating polymeric nanofibres, which can be exploited as carriers for developing a series of new drug delivery systems (DDS) (Ignatious et al., 2010; Kenawy et al., 2002; Nagy et al., 2010; Vigh et al., 2013; Yu et al., 2013) . Using ES processes, not only the above-mentioned disadvantages can be eliminated, but also some new types of solid dispersions can be developed for poorly water-soluble drugs, such as third generation solid dispersions and structural solid dispersions (Yu et al., 2011 (Yu et al., , 2010 . As for the scale-up of ES, recent efforts such as a high speed electrospinning (HSES) have shown the promising future .
Electroblowing (EB) is another scalable version of ES (Kim et al., 2003; Zhou et al., 2009 ) but the use of this technology for producing DDS is still under development .
In this study, our aim was to compare the three solvent based technologies and their applicability for preparing Eudragit E based DDS containing iraconazole (ITR) as a model binary solid dispersion.
ITR is a well-known broad-spectrum antifungal agent (Glasmacher and Prentice, 2006) belonging to BCS II (Wu and Benet, 2005) , the solid dispersions of which have been published with Eudragit E matrix by several authors (Janssens et al., 2010; Jung et al., 1999; Six et al., 2003) . In these works, the miscibility limit and phase separation of amorphous and crystalline ITR were investigated in melt extruded polymer systems in comparison with film casting and SD. The experimental miscibility limit (15% w/w when prepared by film casting or 27.5% w/w prepared by SD below the Tg of the polymer) was found to be strongly dependent on the manufacturing technology and higher value were achieved than expected based on theoretical study (7.07% w/w) (Janssens et al., 2010) . Stability tests were not included in these experimental programs.
Our aim was to examine further details of the mentioned critical characteristics (phase separation and the influence of the solvent evaporation rate) of ITR-Eudragit E systems after producing their solid dispersions by methods and to investigate their stability after a three month-storage by several methods.
Materials and methods
Materials
Crystalline ITR (with a purity of more than 99%) was obtained from Janssen Pharmaceutica (Beerse, Belgium 
Scanning electron microscopy (SEM)
The size and fine texture of the microparticles and fibres were investigated by a JEOL JSM 6380LA (Tokyo, Japan) scanning electron microscope (acceleration voltage: 10 -30 kV).
Each specimen was fixed with conductive double-sided carbon adhesive tape and sputtered with gold -palladium alloy (using a JEOL 1200 instrument) in order to render it electrically conductive.
Residual solvent measurement
The amount of residual solvent in the samples was determined using a static headspace-gas chromatography-mass spectrometry (HS-GC/MS) method. A 20 -100 mg sample was weighed into a 10 mL vial and 1.50 g of anhydrous sodium sulfate and 3 mL of distilled water were added before crimping. The sample was thermostated for 20 minutes at 80 °C and agitated at 600 rpm. A 0.5 mL sample was collected from the headspace with a 2.5 mL headspace syringe which was thermostated at 105 °C. The sample was injected to a split/splitless injector in split injection mode at a 20:1 split ratio. Injector temperature was set at 180 °C. An Agilent 7890 gas chromatograph was used with a RTX-VMS (20 m × 180 µm × 1 µm) column and separation was carried out isothermally at 40 °C with a constant 1 mL/min flow of helium 5.0. The temperature of the transfer line, ion source and quadrupole were set at 250 °C, 230 °C, and 150 °C, respectively. The Agilent 5975C inert XL mass spectrometer was used in selected ion monitoring (SIM) mode with two SIM groups. Target ions were 29 (methanol) and 84 (dichloromethane); qualifier ions were 31 and 86, respectively; dwell time was 50 ms for each ions. External standard calibration was used. The stock solution for methanol was made with distilled water, for dichloromethane with methanol, so two series of calibration solutions were prepared and measured. The calibration ranges were 20 -1000 μg for methanol, and 0.3 -100 μg for dichloromethane.
X-ray powder diffraction (XRPD) measurement
The pure itraconazole, Eudragit E and ITR-loaded microspheres and fibres were analysed with a PANalytical X'pert Pro X-ray MPD diffractometer (Almelo, The Netherlands). The measurements were under CuKα (λ=1.5406 Å), 40 kV and 30 mA as X-ray source with Kb (Ni) filter. The diffraction patterns were collected with 2θ ranging from 4 ° to 42 or 44 °.
Differential scanning calorimetry (DSC) measurement and initial crystallinity determination
Thermal analyses of solid dispersions were carried out using TA Instruments Q2000 apparatus (New Castle, Delaware) in nitrogen atmosphere. The heating rate was 10 °C/min, heating scans were performed from 25 to 200 °C, and TA Instruments Universal Analysis 2000 software was used for data analysis. The determination of the degree of crystallization before the DSC treatment needed special attention as the 20% or 40% API ratio of the samples started to crystallize during heating in the DSC apparatus. Therefore, the "initial crystallinity of the drug" (Six et al., 2002 ) was used for comparison, which means the sum of the integrals of the exothermic crystallization and endothermic melting peaks. When the API in a sample was amorphous, the sum was below the detection level (<3%). For the determination of initial crystallinity, the DSC curves were integrated from 110.0 to 175.0 °C (ranges of crystallization and melting for ITR), the resulted heat of fusion (ΔH) was corrected with the API concentration in the solid dispersions, and it was compared with the fusion enthalpy of pure crystalline ITR. Purified indium standard was used to calibrate the instrument.
Raman mapping
Chemical mapping was carried out on electrospun, electroblown and spray-dried samples using LabRAM 300 micro-Raman spectrometer, manufactured by Horiba Jobin-Yvon (Longjumeau, France) equipped with an external diode laser source (785 nm, 400 mW) and an air cooled CCD detector. The spectra were recorded in the spectral range of 400-1835 cm -1 and the high resolution maps were collected with an objective of ×100 magnification (laser spot size: ∼0.7 μm) and 1 μm step size. The acquired image consisted of 41 × 41 points (pixels), each spectrum was acquired for 10 s, and 2 spectra were averaged in each pixel. For the visualization of the API distribution in the polymer matrix, piece-wise linear base-line correction was applied on all spectra (using the same baseline points for all the maps points and the reference spectra). Afterwards, spectra were normalized to unit area and the component concentrations were estimated with the classical least squares (CLSs) method using the reference spectra of the pure polymer and amorphous ITR. LabSpec 5.41.15 software was used for the spectral analyses and the visualization of chemical maps.
Dissolution test
In vitro drug dissolution tests were performed in 900 mL of 0.1 M HCl solution thermostated at 37±1 °C by means of a Pharma Test PTWS600 dissolution tester equipped with fully automated sampling system (Pharma Test, Hainburg, Germany), using the rotating basket apparatus (USP I) with 100 min -1 stirring speed. Previously ground fibrous samples and spray-dried microparticles containing 50 mg of the API were filled in the basket and the API concentration of the dissolution medium was determined by UV/VIS spectrophotometry (Hewlett-Packard -HP 8453 Diode Array UV/VIS spectrophotometer) at 254 nm based on a calibration line of standards with known concentration.
Contact angle measurements
The wettability of SD, ES and EB samples was characterized by means of a contact angle goniometer (Dataphysics OCA15+; Germany) using the static sessile drop method. 5 µL of 0.1 M HCl solution was dropped onto the surface of tablets compressed from the various samples (ITR preserved its amorphous form in the compressed tablets according to XRPD and DSC analyses.) at room temperature. An optical subsystem was used to capture the drop profile on tablets surface at 0 s and images were analysed using the ellipse fitting method following interface determination.
Results and discussion
3.1. Comparison of yields, productivity, morphology, and residual solvents
The composition of solid dispersions, yields, content uniformity and productivity are summarized in table 2. The yields of solid products could be increased in all cases by increasing ITR concentration. The yield of SD, owing to the handling of the fine powder product, was somewhat less, but it is noted that it can be overcome in case of continuous highvolume production. The deviation in the yields of the electrospun solid dispersions were in connection with the collection efficiency of the fibrous product. The same is true for the electroblown products. The productivity of ES could be improved effectively from 2 g/h to 56.7 g/h (see table 2) by the use of an assisting airflow. Thus, ~28 times higher productivity could be achieved than by using the single fluid nozzle. The content uniformity of the samples was checked by UV/VIS spectrometry after dissolving accurately measured samples in ethanol. The data suggest that the API content of solid dispersions correspond to the theoretical values in all cases with high content uniformity.
The products prepared by the three (ES, EB and SD) continuous evaporation processes can be seen in figure 1 . In terms of fibre-morphology, the electrospun samples were bead-free fibrous mats with diameters between 0.2 and 5 µm ( figure 1a and b) . The texture of the EB dispersion was also fibrous, but some beaded fibres with low diameter range were detected in case of the EB_20 (see figure 1c and Raman microscopy can indicate specific interactions between components and determine their distribution in solid dispersions; therefore, such analyses were performed too.
The Raman spectra of the ES, EB and SD samples could be very well approximated with the linear combinations of the reference spectra suggesting the absence of specific interactions between the ITR and polymer molecules, in accordance with earlier FT-IR results (Janssens et al., 2010) . Clear evidence of phase separation was expected from the results of Raman mapping experiments. These maps are shown in figure 5 .
The electrospun and electroblown samples ( figure 5a, b, d , and e) did not show any inhomogeneity, while the spray-dried dispersions (figure 5c and f) were not perfectly homogeneous. The mixing level of polymer and ITR molecules remained high when electrostatic field was applied during the drying process. It corresponds to our recently published results (Sóti et al., 2015) . The quantitative DSC data (table 4), in accordance with the XRPD diffraction patterns (figure 2), confirm that the samples were free of any crystal clusters after production.
The three-month storage of solid dispersions did not cause a characteristic change in the diffraction patterns: the XRPD measurements repeated after 90 days still did not show crystalline phase in the solid dispersions above the detection limit of the method (figure 2).
However, differences could be detected by the DSC analysis of spray dried samples within the range of 110 and 175 °C (table 4). The degree of initial crystallinity of dispersions determined according to DSC measurements showed about 10 wt% ITR crystalline part in both SD_20
and SD_40, while the ES and EB products preserved the amorphous state of ITR (see table 4 and figure 2).
Considering the results of the solid phase analyses and the theoretical miscibility limit (cited in the introduction), the thermodynamically favoured phase separation of supersaturated solid dispersions was observed when the drying was proceed, in the case of spray drying, above the Tg of polymer, which facilitates the recrystallization of ITR. In turn, the ES and EB samples, which were prepared at room temperature and resulted in a homogenous distribution of ITR in the polymer matrix, had no tendency to crystallize at the storage conditions. (When the API/matrix ratio was raised from 1:4 to 2:3, the appearance of the mesophase transition and cold crystallization in DSC suggested some phase separation even for the ES and EB samples, but it happened only at submicronic level according to the homogeneous Raman maps.).
Dissolution results
The pharmaceutical performance of the dispersions was evaluated by measuring their dissolution properties in 0.1 M HCl (figure 6). The dissolution tests were performed for comparison on the physical mixtures of the crystalline drug and the polymer. The dissolution was 100% in the case of each solid dispersion sample after 40 min, which is a dramatic increase compared to the physical mixture, which can be ascribed to the fine solid dispersion of the mostly amorphous drug in the highly soluble tertiary amine type carrier. Moreover, by decreasing the API/matrix ratio (from 2:3 to 1:4) the total dissolution time of ITR could be reduced from 40 to 10 min. Based on the results, all the three solvent-based technologies are similarly applicable for improving the dissolution rate of ITR. The phase separation of the matrix and ITR, shown by DSC and Raman results, had no effect on the dissolution profile.
During the applied storage period the solid dispersions preserved the improved dissolution rate and we observed no changes in the drug release. Even the spray dried dispersions behaved the same way in spite of their partial recrystallization according to DSC. In fact only the amorphous state is maintained even after the phase separation during the process, as detected by the Raman mapping, and only longer storage or DSC heat treatment induced the recrystallization.
For the interpretation of the observed differences between the dissolution profiles of the samples with different ITR content, the wettability of the samples was characterized by contact angle measurements. It was observed that the contact angles of the samples containing 40% w/w ITR are significantly higher than those of the 20% w/w ITR contained samples. The results in figure 7 are given for EB samples, which were the same for ES and SD within the margin of error. When the ITR concentration was increased in the dispersions, the DDS became more hydrophobic, thereby reducing the wettability of samples, which caused a somewhat slower drug release.
Conclusions
In this study, the electrospinning, electroblowing (air-assisted electrospinning) and spraydrying methods were compared for preparing itraconazol and Eudragit E solid dispersions.
The productivity of ES could be improved effectively by the use of assisted airflow without any significant change in the drug dissolution profile, physical state and distribution of the API in the polymer matrix at all of the applied API/matrix ratios. The dissolution rate of ITR 
